PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1

PLoS Biology

Volumn 5, Issue 7, 2007, Pages 1494-1503

  Pridgeon, Julia W ^a   Olzmann, James A ^a   Chin, Lih Shen ^a   Li, Lian ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN; PROTEIN KINASE; PTEN INDUCED PUTATIVE KINASE 1; TNF RECEPTOR ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG; CYTOCHROME C; HEAT SHOCK PROTEIN 90; PTEN INDUCED PUTATIVE KINASE; PTEN-INDUCED PUTATIVE KINASE; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; TRAP1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME BINDING; ENZYME PHOSPHORYLATION; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL GENE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; ANIMAL; APOPTOSIS; CELL STRAIN; DRUG ANTAGONISM; ENZYME SPECIFICITY; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; METABOLISM; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PARKINSONISM; PHOSPHORYLATION; POINT MUTATION; PROTEIN BINDING; RAT;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CYTOCHROMES C; HELA CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; PC12 CELLS; PHOSPHORYLATION; POINT MUTATION; PROTEIN BINDING; PROTEIN KINASES; RATS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SUBSTRATE SPECIFICITY; TRANSFECTION;

EID: 34547127902     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.0050172     Document Type: Article

References (41)

1. Lang AE, Lozano AM (1998) Parkinson's disease. First of two parts. N Engl J Med 339: 1044-1053.
2. Farrer MJ (2006) Genetics of Parkinson disease: Paradigm shifts and future prospects. Nat Rev Genet 7: 306-318.
3. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, et al. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1269.
4. Betarbet R, Sherer TB, Greenamyre JT (2002) Animal models of Parkinson's disease. Bioessays 24: 308-318.
5. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160.
6. Hatano Y, Li Y, Sato K, Asakawa S, Yamamura Y, et al. (2004) Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol 56: 424-427.
7. Bonifati V, Rohe CF, Breedveld GJ, Fabrizio E, De Mari M, et al. (2005) Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes. Neurology 65: 87-95.
8. Zadikoff C, Rogaeva E, Djarmati A, Sato C, Salehi-Rad S, et al. (2006) Homozygous and heterozygous PINK1 mutations: Considerations for diagnosis and care of Parkinson's disease patients. Mov Disord 21: 875-879.
9. Hedrich K, Hagenah J, Djarmati A, Hiller A, Lohnau T, et al. (2006) Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: Role of a single hit? Arch Neurol 63: 833-838.
10. Criscuolo C, Volpe G, De Rosa A, Varrone A, Marongiu R, et al. (2006) PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. Mov Disord 21: 1265-1267.
11. Beilina A, Van Der Brug M, Ahmad R, Kesavapany S, Miller DW, et al. (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci U S A 102: 5703-5708.
12. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, et al. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14: 3477-3492.
13. Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, et al. (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain 129: 1720-1731.
14. Nakajima A, Kataoka K, Hong M, Sakaguchi M, Huh NH (2003) BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential. Cancer Lett 201: 195-201.
15. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, et al. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem 280: 34025-34032.
16. Deng H, Jankovic J, Guo Y, Xie W, Le W (2005) Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun 337: 1133-1138.
17. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, et al. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441: 1162-1166.
18. Park J, Lee SB, Lee S, Kim Y, Song S, et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441: 1157-1161.
19. Wang D, Qian L, Xiong H, Liu J, Neckameyer WS, et al. (2006) Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci U S A 103: 13520-13525.
20. Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, et al. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A 103: 10793-10798.
21. Song HY, Dunbar JD, Zhang YX, Guo D, Donner DB (1995) Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J Biol Chem 270: 3574-3581.
22. Chen CF, Chen Y, Dai K, Chen PL, Riley DJ, et al. (1996) A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol Cell Biol 16: 4691-4699.
23. Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, et al. (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275: 3305-3312.
24. Beere HM (2005) Death versus survival: Functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 115: 2633-2639.
25. Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6: 11-22.
26. Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, et al. (2004) Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J Biol Chem 279: 42503-42515.
27. Sim CH, Lio DS, Mok SS, Masters CL, Hill AF, et al. (2006) C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet 15: 3251-3262.
28. Olzmann JA, Brown K, Wilkinson KD, Rees HD, Huai Q, et al. (2004) Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J Biol Chem 279: 8506-8515.
29. Chin LS, Nugent RD, Raynor MC, Vavalle JP, Li L (2000) SNIP, a novel SNAP-25-interacting protein implicated in regulated exocytosis. J Biol Chem 275: 1191-1200.
30. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, et al. (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 279: 13256-13264.
31. Choi J, Sullards MC, Olzmann JA, Rees HD, Weintraub ST, et al. (2006) Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 281: 10816-10824.
32. Chin LS, Raynor MC, Wei X, Chen H, Li L (2001) Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor. J Biol Chem 276: 7069-7078.
33. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, et al. (1999) The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252-256.
34. Lewis Carl SA, Gillete-Ferguson I, Ferguson DG (1993) An indirect immunofluorescence procedure for staining the same cryosection with two mouse monoclonal primary antibodies. J Histochem Cytochem 41: 1273-1278.
35. Li Y, Chin LS, Levey AI, Li L (2002) Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J Biol Chem 277: 28212-28221.
36. Hovius R, Lambrechts H, Nicolay K, de Kruijff B (1990) Improved methods to isolate and subfractionate rat liver mitochondria. Lipid composition of the inner and outer membrane. Biochim Biophys Acta 1021: 217-226.
37. Kirk E, Chin LS, Li L (2006) GRIF1 binds Hrs and is a new regulator of endosomal trafficking. J Cell Sci 119: 4689-4701.
38. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, et al. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 101: 9103-9108.
39. Chen J, Fujii K, Zhang L, Roberts T, Fu H (2001) Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc Natl Acad Sci U S A 98: 7783-7788.
40. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, et al. (1997) Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129-1132.
41. Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, et al. (2002) An in vitro model of Parkinson's disease: Linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci 22: 7006-7015.